This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: The University of Texas System. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Hila Shaim and Her Work in Cell Immunotherapy
Introduction
Hila Shaim is an inventor associated with Houston, Texas, and The University of Texas System. Her patent work focuses on cell immunotherapy, an approach that uses immune cells to help treat cancer.
Latest Patents
Shaim is associated with 1 patent, titled “Cell Immunotherapy for the Treatment of Cancer.” The patent describes compositions containing immune effector cells, including natural killer (NK) cells, supplied with one or more interleukins and optionally equipped with engineered receptors. In certain embodiments, the interleukins are IL-12, IL-21, or both, rather than IL-15. The disclosed NK cells may be used to treat cancers, including glioblastoma.
Career Highlights
Shaim’s patent is connected with The University of Texas System and addresses the development of immune-cell-based cancer treatments. Its described methods center on supporting NK-cell activity through interleukins and, optionally, engineered receptors.
Collaborations
The provided information lists Katy Rezvani and Mayra Shanley as Shaim’s coworkers.
Conclusion
Hila Shaim’s patent work at The University of Texas System concerns NK-cell immunotherapy and potential applications in treating cancer, including glioblastoma.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile